Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT07093801 · RECRUITING
Trial details
- NCT number
- NCT07093801
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-30
- Primary completion
- 2029-03-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.